Two Sigma Investments’s Vaxcyte PCVX Stock Holding History
Bought
Maintained
Sold
Other funds holding PCVX
Two Sigma Investments's PCVX Position: Q3 2026 in Review
Two Sigma Investments reduced its Vaxcyte (PCVX) stake by 64% in Q3 2026, selling an estimated $10.2M and leaving 99,143 shares worth $5.64M. The position accounts for ﹤0.01% of the portfolio, ranked #2044.
Two Sigma Investments first reported a position in PCVX in Q4 2022 and has held it in 8 quarters since. The position peaked at $15.9M in Q2 2026. 356 funds tracked by Wall St. Rank hold PCVX as of Q3 2026.
- Two Sigma Investments held 99,143 shares of Vaxcyte worth $5.64M as of Q3 2026.
- Two Sigma Investments sold 174,733 Vaxcyte shares in Q3 2026, an estimated $10.2M.
- Vaxcyte made up ﹤0.01% of Two Sigma Investments's portfolio in Q3 2026, its #2044 holding.
- Two Sigma Investments first reported a position in Vaxcyte in Q4 2022 and has held it in 8 quarters since.
- Two Sigma Investments's Vaxcyte position peaked at $15.9M in Q2 2026.
- 356 funds tracked by Wall St. Rank held Vaxcyte as of Q3 2026.
Based on Two Sigma Investments's 13F filing for Q3 2026, filed 16 Nov 2026.